Purpose of the Procedure
- Early detection of Nasopharyngeal Carcinoma (NPC) in high-risk individuals.
- Monitoring patient response to radiation or chemotherapy.
- Predicting the risk of cancer recurrence post-treatment.
Protect your health with the EBV DNA test, the most accurate tool for early detection of nasopharyngeal cancer and monitoring treatment progress, ensuring peace of mind and wellness.
Scientific name: Epstein-Barr Virus (EBV) DNA Quantitative PCR for Nasopharyngeal Carcinoma
A quantitative PCR test detecting Epstein-Barr Virus genetic material in blood. It serves as a vital diagnostic and monitoring tool for Nasopharyngeal Carcinoma (NPC) to evaluate treatment efficacy.